Alvaro N. Pinto - Publications

Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 22, 2026

Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study).

Journal: Minerva urology and nephrology

Published: April 23, 2026

Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).

Journal: ESMO open

Published: April 21, 2026

Enfortumab vedotin in ECOG-PS 2 advanced urothelial carcinoma patients: a real-world study from the ARON-2EV project.

Journal: BMC cancer

Published: January 19, 2026

Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 28, 2025

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.

Journal: The New England journal of medicine

Published: October 22, 2025

Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.

Journal: Cancer immunology, immunotherapy : CII

Published: July 05, 2025

Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study.

Journal: Clinical & experimental metastasis

Published: May 24, 2025

Systematic Review of the Definition of Cure and of Curative-intent Treatments in Early Bladder Cancer.

Journal: European urology oncology

Published: March 31, 2025

Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.

Journal: Cell reports. Medicine

Published: February 22, 2025

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.

Journal: Targeted oncology

Published: September 01, 2024

Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 14, 2024